GLP-1 medications are changing the conversation around appetite, weight management and metabolic health. But according to Gil Horsky, reducing appetite does not reduce the importance of nutrition. In many cases, it makes food quality even more important.
In a recent TheMarker article, Gil Horsky explains that when people eat smaller amounts, protein, fibre, vitamins and minerals need to be delivered within less food. Attention must also be given to satiety, body composition and the habits that continue before, during and after medical treatment.
This creates a new opportunity for foodtech. The goal is not to imitate prescription drugs or make unsupported medical claims. It is to develop complementary foods and ingredients that can help people build more sustainable eating patterns, subject to appropriate medical guidance.
Gil Horsky also highlights a broader challenge: people rarely struggle because they have never heard what healthy eating looks like. They struggle because the better choice is often less convenient, less satisfying or harder to repeat. The next generation of food products must reduce that friction rather than demand unlimited willpower from consumers.
Read the full article to explore Gil Horsky’s view of the relationship between GLP-1 treatments, nutrient-dense food and long-term health, and discover why the future of weight management may depend as much on the supermarket shelf as on the clinic.